Patient Safety & Quality Healthcare (PSQH) discussed IV infiltration and it’s potential for life-threatening consequences in a recent article. The piece, “Companies Work to Help Combat IV Infiltrations” includes commentary from ivWatch President and CEO, Gary Warren, and cites the ivWatch Model 400 as a clinician partner helping to deliver improved patient care with constant monitoring of the IV site. Read the full article here.
Learn the facts about infiltration and extravasation here: https://ivwatch.com/the-facts
Congratulations to Holly Novak as she transitions into her new role as Vice President of Regulatory Affairs and Quality.
Congratulations to Pete Spadaro as he transitions into the role of Director of Operations.